Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00875615 · ClinicalTrials.gov registry record · Phase 2

Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

A Phase 2 study of Liver Cancer, sponsored by University of Miami.

Completed
Registry status
Phase 2
Development phase
11
Enrollment target
1
Study location

NCT00875615 is a Phase 2 study of Liver Cancer that has completed, run by University of Miami. The registered enrollment target is 11 participants, below the 448-participant average among 78 other Liver Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00875615, a Phase 2 study of Liver Cancer, has completed, sponsored by University of Miami.

COMPLETED
Registry status
Phase 2
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Drugs used in chemotherapy, such as cisplatin and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Infusing chemotherapy directly into the liver and giving it together with sorafenib may kill more tumor cells. PURPOSE: This phase II trial is studying the side effects of infusing cisplatin or carboplatin directly into the liver and giving it together with sorafenib in treating patients with liver cancer that cannot be removed by surgery.

Conditions Studied

Liver Cancer

Interventions

  • DRUG Carboplatin
  • DRUG Cisplatin
  • DRUG Sorafenib

Study Locations (1)

Florida

  • University of Miami Sylvester Comprehensive Cancer Center - Miami - Miami

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2008-12
Est. Completion 2012-06
Phase Phase 2

Sponsor

University of Miami

721 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00875615

The ClinicalTrials.gov registry entry for NCT00875615 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 448-participant average among 78 other Liver Cancer trials with a reported enrollment target (98% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Liver Cancer appearing as the primary indexed condition, and to 3 interventions - of which Carboplatin is the first listed.

NCT00875615 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT00875615 about?

NCT00875615 is a clinical study titled "Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery". RATIONALE: Drugs used in chemotherapy, such as cisplatin and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and b...

What is the current status of trial NCT00875615?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2008-12. Estimated completion is 2012-06.

What conditions does trial NCT00875615 study?

This clinical trial studies the following conditions: Liver Cancer.

What interventions are being tested in trial NCT00875615?

The interventions under investigation include: Carboplatin (DRUG), Cisplatin (DRUG), Sorafenib (DRUG).

Who is sponsoring clinical trial NCT00875615?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00875615 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Liver Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Liver Cancer

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.